Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Franziska von Haxthausen"'
Autor:
Franziska von Haxthausen, Linda Reinhard, Hans O. Pinnschmidt, Michael Rink, Armin Soave, Elion Hoxha, Rolf A. K. Stahl
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Membranous nephropathy (MN) is an autoimmune disease caused by binding of circulating antibodies to podocyte antigens in the kidney. For decades and still today primary MN has been considered to have an unspecified IgG4-driven autoimmune genesis, whi
Externí odkaz:
https://doaj.org/article/36066126ba4a4e1a8ee3ad0c7858d507
Publikováno v:
Pflügers Archiv - European Journal of Physiology. 469:989-996
Since the discovery of the phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type-1 domain-containing 7A (THSD7A) as endogenous antigens involved in the development of membranous nephropathy (MN) in over 80% of adult patients, substantial progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013178bb757585c2de9c8de705f3b4f4
https://doi.org/10.1007/s00424-017-2000-4
https://doi.org/10.1007/s00424-017-2000-4
Autor:
Linda Reinhard, Rolf A.K. Stahl, Elion Hoxha, Michael Rink, Franziska von Haxthausen, Hans O. Pinnschmidt, Armin Soave
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, Vol 9 (2018)
Membranous nephropathy (MN) is an autoimmune disease caused by binding of circulating antibodies to podocyte antigens in the kidney. For decades and still today primary MN has been considered to have an unspecified IgG4-driven autoimmune genesis, whi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f648b00fc84275809f519f2ac5a507
https://pubmed.ncbi.nlm.nih.gov/30619370
https://pubmed.ncbi.nlm.nih.gov/30619370
Autor:
Uwe Kordes, Jonas Harder, André O. von Bueren, Christian Hagel, Franziska von Haxthausen, Julia Fehlert, András Treszl, Meike Kern
Publikováno v:
Journal of Neuro-Oncology. 112:191-197
Ependymomas comprise 8 % of all intracranial tumors in children
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bb1660f8889a3cdc4d8ba25bc0a3451
https://doi.org/10.1007/s11060-013-1062-1
https://doi.org/10.1007/s11060-013-1062-1
Autor:
Samuel Huber, Nina D. Thiele, Alexander Quaas, Tanja Schoknecht, Niklas Steffens, Christoph Schramm, Ansgar W. Lohse, Franziska von Haxthausen, B Höh, Antonella Carambia, F Glaser, Dorothee Schwinge, Johannes Herkel, Benjamin Otto
Publikováno v:
Journal of hepatology. 66(4)
Background & Aims Reduced numbers of regulatory T cells (Treg) have been reported in patients with primary sclerosing cholangitis (PSC); therefore, Treg expansion might serve as a therapeutic approach. Here, we explored whether treatment with IL-2/IL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea7e44a7f0964c169b7db90e8a4e1b5a
https://pubmed.ncbi.nlm.nih.gov/27965154
https://pubmed.ncbi.nlm.nih.gov/27965154